Project Number EUJPND-CIHR-Postuma-458 Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Year 2016 View Full Project Details for Caffeine as a Therapeutic Agent in Parkinson's disease Research Categorization Primary Disease / Condition Lewy Body Dementias CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator Postuma, Ronald B Principal Investigator First Name Ronald B Principal Investigator Last Name Postuma Awardee Organization Research Institute of the McGill University Health Centre Contact PI Country Canada Project Detail FY Overall Cost $63,456 Funding Organization Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Organization Country Canada Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
